Clinical Trials

ELIAS Animal Health has developed a unique immunotherapy treatment protocol which may permit the dog’s immune system to attack its own cancer cells. ELIAS Cancer Immunotherapy (ECI®)—a vaccine-enhanced adoptive cell therapy—has demonstrated effectiveness in clinical trials in both canines and humans, while avoiding or minimizing the need for chemotherapy or radiation treatment.

Canine Osteosarcoma: ECI® combined with novel adjuvant and limb-spare surgery

Enrollment for this study (ECIP-OSA-01) is now open.

“The T cell expansion is a huge component that, to my knowledge, none of the other autologous products are even trying to replicate.”

Zachary Wright, DVM, DACVIM (Oncology)

VCA Animal Diagnostic Clinic